Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

Eli Lilly ( LLY 0.53%) is one of the undisputed leaders in the fast-growing market for weight-management medicines. Following recent clinical wins, the company may even be taking the lead ahead of its ...

A former Boone County bean field is where Lilly will research, develop and manufacture the medicines of the future. Company leaders joined government officials in breaking ground on the Lilly Medicine ...

Pharmaceutical manufacturing giant Eli Lilly and Co. is exploring potential economic incentives for a $5.9B biomanufacturing plant in Northeast Houston, according to documents filed with the state ...

A major pharmaceutical company that has invested heavily in North Carolina is planning multiple new factories in the U.S. Eli Lilly tags Triangle for long-term growth 2024 Space Awards: Economic ...

Eli Lilly’s first quarter saw rapid revenue growth, but the market responded negatively due to profit shortfalls and emerging ...

But Eli Lilly's supply woes began to ease earlier this year, and the Food and Drug Administration removed tirzepatide, the active ingredient in Mounjaro and Zepbound, from its shortage list.

Eli Lilly announced the results of a clinical trial for its new pill, which the company said causes nearly 8% weight loss at certain dosages.

More campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana. Lilly, a pharmaceutical company, employs more than 12.000 people in Indianapolis and more than 42,000 worldwide.

Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 trillion stock and the first healthcare company to do so. Trading at $852 per ...

WEST LAFAYETTE, Ind. — Purdue University and Eli Lilly and Company are strengthening their long-standing strategic research collaboration with the announcement of the Eli Lilly and Company and Purdue… ...